HGT-2610

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHGT-2610
Drug Alias Nameenzyme replacement therapy (Shire)HGT-2610
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionGalactocerebrosidase modulators
TargetsGalactocerebrosidase
Therapy Area/IndicationsLeukodystrophy, Globoid Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesShire
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire
Active IndicationsN/A
Inactive IndicationsLeukodystrophy, Globoid Cell

Other Information

ATC CodeN/A
Related LinksN/A